ExCEEd Orphan continues cooperation with Novartis Gene Therapies for Zolgensma®
By controluser
ExCEEd Orphan will continue next year in cooperation with Novartis Gene Therapies (previously …
By controluser
ExCEEd Orphan will continue next year in cooperation with Novartis Gene Therapies (previously …
By controluser
AveXis receives EC approval and activates “Day One” access program for Zolgensma®, the …
By controluser
Little Max is the first patient with spinal muscular atrophy who received systemic …
By controluser
Czech Health Insurance companies recently approved reimbursement of breakthrough gene therapy treatment for …
By controluser
AveXis receives positive CHMP opinion for Zolgensma®, the only gene therapy for spinal …
By controluser
Novartis receives approval from Japanese Ministry of Health, Labour and Welfare for Zolgensma® …